Currently browsing the Life Science Category

Posts covering topics such as: biology, genetics, viruses, health care...
Recommended posts: Complete Work of Charles Darwin Online - The Inner Life of a Cell - Feed your Newborn Neurons - New Understanding of Human DNA - Bye Bye Bees - Energy Efficiency of Digestion - Microbe Types

Sustainable Ocean Farming

Farming the Sea: why eating kelp is good for you and good for the environment

There are serious problems with our ability to grow healthy food for the number of people we have today (and will have in the future). Innovations have allowed us to feed ourselves. But the damage done to topsoil and other damage including pollution of our rivers is huge. Overfishing and factory farms are keeping us going today but are doing immense damage and are not sustainable.

Seed companies abusing the corrupt government patent systems creates even more damage. We need better solutions. We have many people doing great things but we need to do much more. Ocean farming is one of many areas we should expand. And we should greatly reduce the use of factory farms, antibiotics for livestock, overfishing and the overuse of pesticides.

How an Army of Ocean Farmers are Starting an Economic Revolution

So we all went on a search for sustainability. I ended up in Northern Canada on an aquaculture farm. At that point aquaculture was supposed to be the great solution to overfishing, but when I got there I found more of the same, only using new technologies to pollute local waterways with pesticides and pumping fish full of antibiotics.

I never thought climate change had anything to do with my life. But it does. From my vantage point, climate change is not an environmental issue at all — it’s an economic issue.

As ocean farmers, we reject aquaculture’s obsession with monoculture, an obsession similar to that of modern land farming. Our goal is diversity. It’s a sea-basket approach:We grow two types of seaweeds, four kinds of shellfish, and we harvest salt. But with over 10,000 edible plants in the ocean, we’ve barely scratched the surface.

Instead of repeating history we’re building infrastructure from seed-to-harvest-to-market. We’re starting nonprofit hatcheries so that our farmers can access low-cost seed. We’re creating ocean seed banks so that the Monsantos of the world can’t privatize the source of our food and livelihoods.

Related: SelFISHingThe State of the Oceans (2011)Rethinking the Food Production System (2008)

Medicinal Plants

Another great webcast from SciShow. In this webcast Hank Green discusses how we have used plants to treat us and improve our health.

In the webcast, Hank also does a good job touching a bit on the scientific inquiry process (which is something I find interesting and I think is very important for people living in society today to understand).

Related: Youyou Tu, The First Chinese Woman to Win a Nobel PrizeRubber TreesPhotosynthesis: Science Explained

Gut Bacteria Explored as Medical Treatment – even for Cancer

The interaction between gut bacteria and human health continues to be a fertile area of medical research. It appears to be in the very early days of such research. Of course, as I have said before, headline making news often doesn’t result in medical breakthrough, and even when it does a decade isn’t a long wait for it to happen.

How Gut Bacteria Are Shaking Up Cancer Research

In November, University of Chicago researchers wrote that giving mice Bifidobacterium, which normally resides in the gastrointestinal tract, was as effective as an immunotherapy in controlling the growth of skin cancer. Combining the two practically eliminated tumor growth. In the second study, scientists in France found that some bacterial species activated a response to immunotherapy, which didn’t occur without the microbes.

The complex interactions involved in human health is another area that has huge room for research going forward.

Related: Some Bacteria Might Fight Cancer (2008)Cancer Vaccines (2011)Using Diatom Algae to Deliver Chemotherapy Drugs Directly to Cancer Cells (2015)Webcast of a T-cell Killing a Cancerous Cell (2012)

Webcasts on the Human Microbiome

The human microbiome is a very interesting aspect of our health and biology.

The 99% figure they quote is mainly silly. It might be technically accurate, but it is much more misleading than accurate (if it is accurate). We have more non-human cells than human but those cells are much smaller and we are overwhelmingly made up of human cells by weight (95+%).

The complexity of healthy bodies is far from understood. It is interesting to watch our understanding of the balancing act going on inside of us. Many foreign “invaders” are critical to our health.

Related: People are Superorganisms With Microbiomes of Thousands of SpeciesPeople Have More Bacterial Cells than Human CellsFighting Superbugs with Superhero BugsWe Have Thousands of Viruses In Us All the Time

Continue reading

Our Poor Antibiotic Practices Have Sped the Evolution of Resistance to Our Last-Resort Antibiotic

The risk to human health due to anti-biotic resistance continues to be a huge public health concern. Our continued failure to adopt better antibiotics practices increase that risk. Those bad practices include feeding large amounts of antibiotics to farm animals to increase yields and increase the evolution of drug resistant bacteria.

Resistance to last-resort antibiotic has now spread across globe

The genes found in Denmark and China are the same, says Aarestrup, suggesting mcr-1 has travelled, rather than arising independently in each place. It is thought to have emerged originally in farm animals fed colistin as an antibiotic growth promoter.

In 2012, the World Health Organization called colistin critically important for human health, meaning its use in animals should be limited to avoid promoting resistance. Yet in 2013, the European Medicines Agency reported that polymyxins were the fifth most heavily used type of antibiotic in European livestock.

Colistin, an antibiotic that previously was a last defense against resistant strains of bacteria, is even more heavily used in China than Europe (it is not clear how the resistance developed but it likely developed in one place, most likely China, and spread rather than emerging in 2 places). The USA has been more responsible and has not risked human health through the widespread use of colistin in farm animals. But the USA still uses antibiotics irresponsibly to promote livestock growth at the risk of human lives being lost as antibiotics lose their effectiveness as bacteria evolve resistance (which is sped by poor practices in agri-business).

Antibiotic resistance is an enormous risk to human health. Millions of lives could be lost and we have have years to reduce those risks. Scientists are doing a great deal of work to find new tools to help us avoid catastrophe but we have been far too careless in our practices, especially in the massive use of antibiotics merely to boost yields in agribusiness.

Related: Are you ready for a world without antibiotics? (2010)80% of the Antibiotics in the USA are Used in Agriculture and AquacultureWhat Happens If the Overuse of Antibiotics Leads to Them No Longer Working?Waste Treatment Plants Result in Super Bacteria (2009)CDC Again Stresses Urgent Need to Adjust Practices or Pay a Steep Price (2013)

Using Diatom Algae to Deliver Chemotherapy Drugs Directly to Cancer Cells

I am thankful for scientists doing the time consuming and important research to find new ways to fight disease. Here is an interesting webcast discussing how chemotherapy is used to fight cancer and how scientists are looking to algae to deliver the chemotherapy drugs to better target cancer cells (while not savaging our health cells).

I am also thankful to the funding sources that pay for this research (and for cool explanations of science, like SciShow).

Read more about the genetically engineered algae kills 90% of cancer cells without harming healthy ones. The algae are a diatom and many diatoms look very cool.

Sadly the actual research paper (by government funded university professors) is published by a closed science publisher (when are we finally going to stop this practice that was outdated over a decade ago?). Thankfully those responsible for SciShow are much more interested in promoting science than maintaining outdated business models (in direct contrast to so many science journal publishers).

Related post on cool delivery methods for life saving drugs: Using Bacteria to Carry Nanoparticles Into CellsSelf-Assembling Cubes Could Deliver Medicine (2006)Nanoparticles With Scorpion Venom Slow Cancer SpreadNASA Biocapsules Deliver Medical Interventions Based Upon What They Detect in the Body

200,000 People Die Every Year in Europe from Adverse Drug Effects – How Can We Improve?

A new integrated computational method helps predicting adverse drug reaction more reliably than with traditional computing methods. This improved ability to foresee the possible adverse effects of drugs may entail saving many lives in the future.

Most computer tools employed today to detect possible adverse effects of compounds that are candidates for new medicines are based on detecting labile fragments in the drug’s structure. These fragments can potentially transform to form reactive metabolites, which can have toxic properties. This is what is known as idiosyncratic toxicity and is a big headache for the pharmaceutical industry, as it tends to be detected in late development stages of the drug and even when it is already on the market, often causing the drug to be withdrawn.

Jordi Mestres, coordinator of the IMIM and UPF research group on Systems Pharmacology at the Biomedical Informatics Program (GRIB) states ‘With this study we have contributed to complementing the detection of these quite unstable fragments, with information on the mechanism of action of the drug, based on three aspects: similarity to other medicines, prediction of their pharmacological profile, and interference with specific biological pathways. The optimal integration of these four aspects results in a clear improvement of our ability to anticipate adverse effects with higher confidence, which entails an extremely positive impact on society’.

In Europe, nearly 200,000 people die every year from adverse drug reactions, seven times more than in traffic accidents. An estimated 5% of hospitalisations are due to adverse effects and they are the fifth most common cause of hospital death. In addition, elderly people tend to take more than one drug at the same time, which multiplies the chances of suffering from adverse effects due to potential drug-drug interactions. In an increasingly aging society, this problem is becoming much more serious.

I think interactions is a hugely important area that needs a great deal more research. Doing so is very complex, which means it isn’t surprising so much more work is needed. The work of my father (and George Box and others) on multi-factorial experimentation is a powerful tool to aid this work (and that connection is likely one of the reasons I find the area of interactions so interesting – along with the realization there is so much benefit possible if we focus in that area more). Previous post on this Curious Cat Science and Engineering blog: Introduction to Fractional Factorial Designed Experiments.

The human and financial costs of adverse effects are very high. That is why the discovery of new medicines is increasingly focused more on predicting possible adverse effects at the initial stages of developing a new drug. This work hopes to contribute to setting the path toward a new generation of more reliable computational tools with regard to predicting the adverse effects of therapeutically-relevant small molecules. Advancing large-scale predictive safety at the pre-clinical phase is now becoming closer than ever, with expectations to lead to safer drugs for the entire population.

The research is published in closed science journal so I don’t link to it. I happily link to open science publications. Read the full press release which includes a link to the closed science journal.

Related: Lifestyle Drugs and RiskRoot Cause, Interactions, Robustness and Design of ExperimentsOne factor at a time (OFAT) Versus Factorial DesignsThe Purpose of Mulit-Factorial Designed Experiments11 Year Old Using Design of ExperimentsOver-reliance on Prescription Drugs to Aid Children’s Sleep?

Fighting Superbugs with Superhero Bugs

As concerns over deadly antibiotic-resistant strains of ‘superbug’ bacteria grow, scientists at the Salk Institute are offering a possible solution to the problem: ‘superhero’ bacteria that live in the gut and move to other parts of the body to alleviate life-threatening side effects caused by infections.

Salk researchers reported finding a strain of microbiome Escherichia coli bacteria in mice capable of improving the animals’ tolerance to infections of the lungs and intestines by preventing wasting–a common and potentially deadly loss of muscle tissue that occurs in serious infections. If a similarly protective strain is found in humans, it could offer a new avenue for countering muscle wasting, which afflicts patients suffering from sepsis and hospital-acquired infections, many of which are now antibiotic resistant.

images of E. coli bacteria, salmonella typhimurium and burkholderia thailandensis

Salk scientists found a strain of E. coli bacteria (left) that were able to stop muscle wasting in mice infected with either Salmonella Typhimurium (center) and Burkholderia thailandensis (right). Image courtesy the Salk Institute.

“Treatments for infection have long focused on eradicating the offending microbe, but what actually kills people aren’t the bacteria themselves–it’s the collateral damage it does to the body,” says Janelle Ayres, a Salk assistant professor in the Nomis Foundation Laboratories for Immunobiology and Microbial Pathogenesis and senior researcher on the study.

“Our findings suggest that preventing the damage–in this case muscle wasting–can stave off the most life-threatening aspects of an infection,” she adds. “And by not trying the kill the pathogen, you’re not encouraging the evolution of the deadly antibiotic-resistant strains that are killing people around the world. We might be able to fight superbugs with ‘superhero’ bugs.”

Once the most powerful and revolutionary of drugs, antibiotics appear to have reached their limits, due to the ability of bacteria to rapidly evolve resistance to the medicines. The rise of antibiotic resistance presents a grave threat to people around the world, as diseases once easily controlled repel all attempts at treatment. A recent study found that up to half of the bacteria that cause infections in US hospitals after a surgery are resistant to standard antibiotics.

In the United States alone, two million people annually become infected with bacteria that are resistant to antibiotics and at least 23,000 people die each year as a direct result of these infections, according to the U.S. Centers for Disease Control.

Continue reading

Funding Sources for Independent Postdoctoral Research Projects in Biology

Here is a nice list of funding sources for independent postdoctoral research projects in biology.

Some examples:

Directory of select science and engineering scholarships and fellowships for undergraduates, graduates and faculty on our blog.

Related: Science, Engineering and Math Fellowships (2008)Proposal to Triple NSF GFRP Awards and the Size of the Awards by 33% (2007)HHMI Expands Support of Postdoctoral ScientistsNSF Graduate Research Fellow Profiles (Sergy Brin, Google co-founder)

Youyou Tu: The First Chinese Woman to Win a Nobel Prize

The Nobel Prize in Physiology or Medicine 2015 was divided, one half jointly to William C. Campbell (born Ireland, now USA) and Satoshi Ōmura (Japan) “for their discoveries concerning a novel therapy against infections caused by roundworm parasites” and the other half to Youyou Tu (China) “for her discoveries concerning a novel therapy against Malaria”.

Youyou Tu is the first Chinese woman to win a Nobel Prize.

Diseases caused by parasites have plagued humankind for millennia and constitute a major global health problem. In particular, parasitic diseases affect the world’s poorest populations and represent a huge barrier to improving human health and wellbeing. This year’s Nobel Laureates have developed therapies that have revolutionized the treatment of some of the most devastating parasitic diseases.

William C. Campbell and Satoshi Ōmura discovered a new drug, Avermectin, the derivatives of which have radically lowered the incidence of River Blindness and Lymphatic Filariasis, as well as showing efficacy against an expanding number of other parasitic diseases. Youyou Tu discovered Artemisinin, a drug that has significantly reduced the mortality rates for patients suffering from Malaria.

These two discoveries have provided humankind with powerful new means to combat these debilitating diseases that affect hundreds of millions of people annually. The consequences in terms of improved human health and reduced suffering are immeasurable.

image of Artemisinin

via Noble Prize website

Malaria was traditionally treated by chloroquine or quinine, but with declining success. By the late 1960s, efforts to eradicate Malaria had failed and the disease was on the rise. At that time, Youyou Tu in China turned to traditional herbal medicine to tackle the challenge of developing novel Malaria therapies. From a large-scale screen of herbal remedies in Malaria-infected animals, an extract from the plant Artemisia annua emerged as an interesting candidate.

However, the results were inconsistent, so Tu revisited the ancient literature and discovered clues that guided her in her quest to successfully extract the active component from Artemisia annua. Tu was the first to show that this component, later called Artemisinin, was highly effective against the Malaria parasite, both in infected animals and in humans. Artemisinin represents a new class of antimalarial agents that rapidly kill the Malaria parasites at an early stage of their development, which explains its unprecedented potency in the treatment of severe Malaria.

Youyou Tu was born in 1930 in China and is a Chinese citizen. She graduated from the Pharmacy Department at Beijing Medical University in 1955. From 1965-1978 she was Assistant Professor at the China Academy of Traditional Chinese Medicine, from 1979-1984 Associate Professor and from 1985 Professor at the same Institute. From 2000, Tu has been Chief Professor at the China Academy of Traditional Chinese Medicine. She doesn’t have a doctorate, very rare for a Nobel Prize winner in the sciences.

Read the full press release

Related: Nobel Prize in Physiology or Medicine 2012 for Reprogramming Cells to be PluripotentNobel Prize in Physiology or Medicine 2008Parasites in the Gut Help Develop a Healthy Immune System2011 Nobel Prize in Physiology or MedicineVideo showing malaria breaking into cell

Cancer Rates Consistent Across Species Instead of Increasing Due to Body Mass

It would seem sensible to think cancer should be more prevalent in species with a huge number of cells, and thus more cells to become cancerous. But cancer risk doesn’t increase in this way. This interesting, open source paper, sheds some light on what is behind this.

Solutions to Peto’s paradox revealed by mathematical modelling and cross-species cancer gene analysis

Whales have 1000-fold more cells than humans and mice have 1000-fold fewer; however, cancer risk across species does not increase with the number of somatic cells and the lifespan of the organism. This observation is known as Peto’s paradox. How much would evolution have to change the parameters of somatic evolution in order to equalize the cancer risk between species that differ by orders of magnitude in size? Analysis of previously published models of colorectal cancer suggests that a two- to three-fold decrease in the mutation rate or stem cell division rate is enough to reduce a whale’s cancer risk to that of a human. Similarly, the addition of one to two required tumour-suppressor gene mutations would also be sufficient.

We surveyed mammalian genomes and did not find a positive correlation of tumour-suppressor genes with increasing body mass and longevity. However, we found evidence of the amplification of TP53 in elephants, MAL in horses and FBXO31 in microbats, which might explain Peto’s paradox in those species. Exploring parameters that evolution may have fine-tuned in large, long-lived organisms will help guide future experiments to reveal the underlying biology responsible for Peto’s paradox and guide cancer prevention in humans.

Elephants in Kenya

Elephants in Kenya by John Hunter. See more photos from my trip to Kenya.

In another way it would make sense that large animals would have hugely increased risks of cancer. As they evolved, extremely high cancer rates would be a much bigger problem for them. Therefore it wouldn’t be surprising to find they have evolved a way of reducing cancer risks.

Despite these limitations, we found genes that have been dramatically amplified in specific mammalian genomes, the most interesting of which is the discovery of 12 TP53 copies in the genome of the African elephant. We subsequently cloned those genes and identified 19 distinct copies of TP53 in African elephants and 15–20 in Asian elephants [1]. Another potential lead for solving Peto’s paradox is MAL, which is found to have eight copies in the horse genome and two in microbat. This could be an example of convergent evolution where a large animal (horse) and a small, long-lived animal (microbat) both evolved extra copies of the same gene to overcome their increased risk of cancer. Further analysis and experimentation would need to be performed to determine the function of these copies and whether or not they provide enhanced suppression of carcinogenesis.

The researchers have found an interesting potential explanation for how that has been accomplished.

Related: The Only Known Cancerless Animal (the naked mole rat)Webcast of a T-cell Killing a Cancerous CellResearchers Find Switch That Allows Cancer Cells to SpreadCancer Vaccines

  • Recent Comments:

    • Vignesh P: very useful information.thank you for sharing It is so good blog !
    • Dustin McEarchern: Love the use of technology to improve lives. Really great story.
    • Albert Duncan: If the US is bad take a look at the EU and their common fisheries policy. Fisherman throws a...
    • Ashley: Woww…. what a beautiful bird. I love the picture.
    • Mart: very interesting article, thanks for sharing.
    • Anonymous: Nuts, full of good fats and fiber, are health food for the heart. A number of studies show that...
    • jetpara: This is really good news. I love technology. Life will change about technology
    • Cihan Uysal: thank you
  • Recent Trackbacks:

  • Links